Chandigarh

Rg Lifesciences

GST04**********1ZTTrustSEAL 3 yrs

 3.8 (41)
90% Response Rate
  • Legal Status of Firm

    Proprietorship

  • GST Registration Date

    Dec 2021

  • Annual Turnover

    1.5 - 5 Cr

  • Indiamart Member Since

    Jun 2022

Cefuroxime Axetil Tablets Ip 250 Mg

₹ 3,100/BoxProduct Brochure

Strength250mg
FormulationCefuroxime
Dosage FormTablet
CompositionCEFUROXIME 250
Packaging Size1*10 Tablets
FlavorOrange
FormTablets
Also givesPCD Pharma Franchise, Third Party Manufacturing
Packaging TypeALU*ALU
Country of OriginMade in India
AvailabilityIn Stock
View in Hindi सेफुरोक्साइम एक्सिटिल टैबलेट IP 250 mg
Backed by rich industrial experience we are offering cefuroxime  to our clients providing best services to our clients at reasonable rates 

Shipping Information

PriceExcluding all taxes
ShippingAs per delivery location

Product Image

Cefuroxime Axetil Tablets Ip 250 Mg image 1Cefuroxime Axetil Tablets Ip 250 Mg image 2Cefuroxime Axetil Tablets Ip 250 Mg image 3Cefuroxime Axetil Tablets Ip 250 Mg image 4Cefuroxime Axetil Tablets Ip 250 Mg image 5Cefuroxime Axetil Tablets Ip 250 Mg image 6

About the Company

GST Registration Date
Dec 2021
Legal Status of Firm
Proprietorship
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
1.5 - 5 Cr
IndiaMART Member Since
June 2022
GST
04**********1ZT

Established in the year of 2021, We Rg Lifesciences are Trader, Wholesaler And Distributor of Pharmaceutical Capsules, Pharmaceutical Syrup, Pharmaceutical Tablets, Protein Powder, Energy Drink Powder.We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers. 

For our accomplishment story, we are grateful to our Mr. Chandresh Vishwakarma ,whose continual backing and direction have been useful to us for attaining exponential development in the current market.